Smaldone Alsup Laurie
Insider CIK 1589602 · BB Director · KBIO Director · TBPH Director · ARVN Director · KNTE Director · PRDS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 6,000 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 13,500 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 6,000 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 6,000 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 6,000 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 28,000 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 22,044 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 23,576 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 24,258 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 13,398 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer | 2026-09-23 | 2026-09-24 | 6,009 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer | 2026-09-23 | 2026-09-24 | 74,980 | — | $0 | 6,009 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 13,398 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 24,258 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 23,576 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 22,044 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 28,000 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 6,000 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 6,000 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 6,000 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 6,000 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 13,500 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer | 2026-09-23 | 2026-09-24 | 6,009 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer | 2026-09-23 | 2026-09-24 | 74,980 | — | — | 6,009 | SEC↗ |
| ARVN ARVINAS, INC. | A Award deriv | 2026-06-24 | 2026-06-26 | 22,714 | — | $0 | 22,714 | SEC↗ |
| ARVN ARVINAS, INC. | A Award | 2026-06-24 | 2026-06-26 | 15,527 | — | $0 | 41,572 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2026-06-12 | 2026-06-16 | 13,398 | — | $0 | 13,398 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2026-06-12 | 2026-06-16 | 6,009 | — | $0 | 80,989 | SEC↗ |
| ARVN ARVINAS, INC. | A Award deriv | 2025-06-25 | 2025-06-27 | 23,105 | — | $0 | 23,105 | SEC↗ |
| ARVN ARVINAS, INC. | A Award | 2025-06-25 | 2025-06-27 | 16,025 | — | $0 | 26,045 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2025-05-19 | 2025-05-21 | 24,258 | — | $0 | 24,258 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2025-05-19 | 2025-05-21 | 10,649 | — | $0 | 74,980 | SEC↗ |
| BB BLACKBERRY Ltd | A Award deriv | 2024-06-25 | 2024-06-26 | 5,994 | — | $0 | 292,923 | SEC↗ |
| BB BLACKBERRY Ltd | A Award deriv | 2024-05-31 | 2024-06-04 | 17,763 | — | $0 | 286,929 | SEC↗ |
| ARVN ARVINAS, INC. | A Award deriv | 2024-05-29 | 2024-05-31 | 9,070 | — | $0 | 9,070 | SEC↗ |
| ARVN ARVINAS, INC. | A Award | 2024-05-29 | 2024-05-31 | 5,899 | — | $0 | 10,020 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2024-05-08 | 2024-05-10 | 23,576 | — | $0 | 23,576 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2024-05-08 | 2024-05-10 | 10,537 | — | $0 | 64,331 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 60,751 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 20,250 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 20,250 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 25,000 | — | $0 | 0 | SEC↗ |
| BB BLACKBERRY Ltd | A Award deriv | 2024-02-29 | 2024-03-04 | 17,763 | — | $0 | 269,166 | SEC↗ |
| BB BLACKBERRY Ltd | A Award deriv | 2023-11-30 | 2023-12-04 | 13,554 | — | $0 | 251,403 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | D To issuer deriv | 2023-08-31 | 2023-08-31 | 37,500 | — | $0 | 0 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | D To issuer deriv | 2023-08-31 | 2023-08-31 | 75,000 | — | $0 | 0 | SEC↗ |
| BB BLACKBERRY Ltd | A Award deriv | 2023-08-31 | 2023-09-01 | 8,953 | — | $0 | 237,849 | SEC↗ |
| ARVN ARVINAS, INC. | A Award deriv | 2023-06-15 | 2023-06-20 | 12,787 | — | $0 | 12,787 | SEC↗ |
| ARVN ARVINAS, INC. | A Award | 2023-06-15 | 2023-06-20 | 4,121 | — | $0 | 4,121 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award deriv | 2023-06-12 | 2023-06-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | A Award deriv | 2023-06-01 | 2023-06-02 | 37,500 | — | $0 | 37,500 | SEC↗ |
| BB BLACKBERRY Ltd | A Award deriv | 2023-05-31 | 2023-06-01 | 9,259 | — | $0 | 228,896 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2023-05-02 | 2023-05-04 | 22,044 | — | $0 | 22,044 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2023-05-02 | 2023-05-04 | 9,132 | — | $0 | 53,794 | SEC↗ |
| BB BLACKBERRY Ltd | A Award deriv | 2023-02-28 | 2023-03-01 | 12,736 | — | $0 | 219,637 | SEC↗ |
| BB BLACKBERRY Ltd | A Award deriv | 2022-11-30 | 2022-12-01 | 10,353 | — | $0 | 206,901 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | A Award deriv | 2022-09-14 | 2022-09-16 | 75,000 | — | $0 | 75,000 | SEC↗ |
| BB BLACKBERRY Ltd | A Award deriv | 2022-08-31 | 2022-09-01 | 8,653 | — | $0 | 196,548 | SEC↗ |
| ARVN ARVINAS, INC. | A Award deriv | 2022-06-16 | 2022-06-21 | 10,192 | — | $0 | 10,192 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award deriv | 2022-06-13 | 2022-06-15 | 20,250 | — | $0 | 20,250 | SEC↗ |
| BB BLACKBERRY Ltd | A Award deriv | 2022-05-31 | 2022-06-01 | 8,859 | — | $0 | 187,895 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2022-04-26 | 2022-04-28 | 28,000 | — | $0 | 28,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2022-04-26 | 2022-04-28 | 9,852 | — | $0 | 44,662 | SEC↗ |
| BB BLACKBERRY Ltd | A Award deriv | 2022-02-28 | 2022-03-01 | 7,758 | — | $0 | 179,036 | SEC↗ |
| BB BLACKBERRY Ltd | A Award deriv | 2021-11-30 | 2021-12-02 | 5,547 | — | $0 | 171,278 | SEC↗ |
| BB BLACKBERRY Ltd | A Award deriv | 2021-08-31 | 2021-09-01 | 4,694 | — | $0 | 165,731 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award deriv | 2021-06-11 | 2021-06-14 | 20,250 | — | $0 | 20,250 | SEC↗ |
| ARVN ARVINAS, INC. | A Award deriv | 2021-06-08 | 2021-06-10 | 7,511 | — | $0 | 7,511 | SEC↗ |
| BB BLACKBERRY Ltd | A Award deriv | 2021-05-28 | 2021-06-01 | 5,560 | — | $0 | 161,037 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2021-04-27 | 2021-04-29 | 6,000 | — | $0 | 6,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2021-04-27 | 2021-04-29 | 9,828 | — | $0 | 34,810 | SEC↗ |
| BB BLACKBERRY Ltd | A Award deriv | 2021-02-26 | 2021-03-02 | 5,245 | — | $0 | 155,477 | SEC↗ |
| BB BLACKBERRY Ltd | A Award deriv | 2020-11-30 | 2020-12-02 | 8,823 | — | $0 | 150,232 | SEC↗ |
| BB BLACKBERRY Ltd | A Award deriv | 2020-08-31 | 2020-09-02 | 9,927 | — | $0 | 141,409 | SEC↗ |
| ARVN ARVINAS, INC. | A Award deriv | 2020-06-03 | 2020-06-04 | 12,000 | — | $0 | 12,000 | SEC↗ |
| BB BLACKBERRY Ltd | A Award deriv | 2020-05-29 | 2020-06-01 | 10,547 | — | $0 | 131,482 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2020-04-28 | 2020-04-30 | 6,000 | — | $0 | 6,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2020-04-28 | 2020-04-30 | 6,635 | — | $0 | 24,982 | SEC↗ |
| ARVN ARVINAS, INC. | A Award deriv | 2019-11-20 | 2019-11-22 | 25,846 | — | $0 | 25,846 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2019-04-30 | 2019-05-02 | 6,000 | — | $0 | 6,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2019-04-30 | 2019-05-02 | 8,385 | — | $0 | 18,347 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2018-05-01 | 2018-05-03 | 6,000 | — | $0 | 6,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2018-05-01 | 2018-05-03 | 8,186 | — | $0 | 9,962 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2018-02-13 | 2018-02-15 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2018-02-13 | 2018-02-15 | 1,500 | — | $0 | 1,500 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2018-02-13 | 2018-02-15 | 1,776 | — | $0 | 1,776 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2015-07-10 | 2015-07-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2014-06-18 | 2014-06-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2013-10-22 | 2013-10-23 | 20,000 | — | $0 | 20,000 | SEC↗ |